Used primarily as an intermediate in Suzuki-Miyaura cross-coupling reactions, this compound enables the synthesis of complex bioactive molecules, particularly in pharmaceutical research. The presence of the boronate ester group allows for efficient palladium-catalyzed coupling with aryl halides, facilitating the construction of biaryl structures found in drug candidates. Its piperazine moiety enhances solubility and can influence binding affinity in target molecules, making it valuable in the development of kinase inhibitors and central nervous system agents. Commonly employed in medicinal chemistry for lead optimization, it supports rapid generation of analogs in structure-activity relationship studies.